Farber disease
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Farber disease Classification and external resources | |
| ICD-10 | E75.2 (ILDS E75.240) |
|---|---|
| ICD-9 | 272.8 |
| OMIM | 228000 |
| DiseasesDB | 29174 |
|
WikiDoc Resources for Farber disease | |
|
Articles | |
|---|---|
|
Most recent articles on Farber disease Most cited articles on Farber disease | |
|
Media | |
|
Powerpoint slides on Farber disease | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Farber disease at Clinical Trials.gov Trial results on Farber disease Clinical Trials on Farber disease at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Farber disease NICE Guidance on Farber disease
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Farber disease Discussion groups on Farber disease Patient Handouts on Farber disease Directions to Hospitals Treating Farber disease Risk calculators and risk factors for Farber disease
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Farber disease | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Farber disease (also known as Farber’s lipogranulomatosis or ceramidase deficiency) describes a group of rare autosomal recessive disorders that cause an accumulation of lipids in the joints, tissues and central nervous system. The disorder affects both males and females.
Presentation and symptoms
Disease onset is typically in early infancy but may occur later in life. Children who have the classic form of Farber’s disease develop neurological shnapps within the first few weeks of life. These symptoms may include moderately impaired mental ability and problems with swallowing. The liver, heart and kidneys may also be affected. Other symptoms may include vomiting, arthritis, swollen lymph nodes, swollen joints, joint contractures (chronic shortening of muscles or tendons around joints), hoarseness and xanthemas which thicken around joints as the disease progresses. Patients with breathing difficulty may require insertion of a breathing tube.
Prognosis
Most children with the disease die by age 2, usually from lung disease. In one of the most severe forms of the disease, an enlarged liver and spleen (hepatosplenomegaly) can be diagnosed soon after birth. Children born with this form of the disease usually die within 6 months.
Treatment
There is no specific treatment for Farber’s disease. Corticosteroids may be prescribed to relieve pain. Bone marrow transplants may improve granulomas (small masses of inflamed tissue) on patients with little or no lung or nervous system complications. Older patients may have granulomas surgically reduced or removed.
Eponym
It is named for Sidney Farber.[1][1]
References
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
